华氏巨球蛋白血症：治疗综述

Waldenström macroglobulinemia: a review of therapy.

作者信息

Gertz Morie A

机构信息

Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.

出版信息

Am J Hematol. 2005 Jun;79(2):147-57. doi: 10.1002/ajh.20363.

DOI:10.1002/ajh.20363

PMID:15929102

Abstract

Waldenström macroglobulinemia is a rare monoclonal gammopathy-associated lymphoplasmacytic lymphoma. Its incidence is only 4 per million per year. This review contains the known published literature specifically on the available management tools for Waldenström macroglobulinemia and is designed to assist clinicians in making management decisions for patients with this uncommon disorder.

摘要

华氏巨球蛋白血症是一种罕见的与单克隆丙种球蛋白病相关的淋巴浆细胞淋巴瘤。其发病率仅为每年百万分之四。本综述包含了专门关于华氏巨球蛋白血症现有治疗工具的已知已发表文献，旨在帮助临床医生对患有这种罕见疾病的患者做出治疗决策。